Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 4 |
Descriptor
| Drug Therapy | 7 |
| Pharmacology | 7 |
| Autism | 4 |
| Hyperactivity | 4 |
| Attention Deficit Disorders | 3 |
| Children | 3 |
| Outcomes of Treatment | 3 |
| Pervasive Developmental… | 3 |
| Research Needs | 3 |
| Symptoms (Individual… | 3 |
| Behavior Change | 2 |
| More ▼ | |
Source
| Australia and New Zealand… | 2 |
| Journal of the American… | 2 |
| Autism: The International… | 1 |
| Journal of Applied Behavior… | 1 |
| Journal of the American… | 1 |
Author
| Aman, Michael G. | 7 |
| Arnold, L. Eugene | 2 |
| Scahill, Lawrence | 2 |
| Vitiello, Benedetto | 2 |
| Anderberg, Emily | 1 |
| Bicard, David F. | 1 |
| Blair, James | 1 |
| Butter, Eric | 1 |
| Carlson, Gabrielle A. | 1 |
| Coccaro, Emil F. | 1 |
| Cook, Amelia M. | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 7 |
| Reports - Research | 5 |
| Information Analyses | 1 |
| Reports - Evaluative | 1 |
Education Level
| Adult Education | 1 |
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 1 |
| Wechsler Intelligence Scale… | 1 |
What Works Clearinghouse Rating
Direct linkScahill, Lawrence; Sukhodolsky, Denis G.; Anderberg, Emily; Dimitropoulos, Anastasia; Dziura, James; Aman, Michael G.; McCracken, James; Tierney, Elaine; Hallett, Victoria; Katz, Karol; Vitiello, Benedetto; McDougle, Christopher – Autism: The International Journal of Research and Practice, 2016
Repetitive behavior is a core feature of autism spectrum disorder. We used 8-week data from two federally funded, multi-site, randomized trials with risperidone conducted by the Research Units on Pediatric Psychopharmacology Autism Network to evaluate the sensitivity of the Children's Yale-Brown Obsessive Compulsive Scale modified for autism…
Descriptors: Autism, Pervasive Developmental Disorders, Scores, Networks
Arnold, L. Eugene; Aman, Michael G.; Li, Xiaobai; Butter, Eric; Humphries, Kristina; Scahill, Lawrence; Lecavalier, Luc; McDougle, Christopher J.; Swiezy, Naomi B.; Handen, Benjamin; Wilson, Krystina; Stigler, Kimberly A. – Journal of the American Academy of Child & Adolescent Psychiatry, 2012
Objective: To follow up on a three-site, 24-week randomized clinical trial (N = 124) comparing antipsychotic medication alone (MED) with antipsychotic medication plus parent training in the behavior management (COMB) of children with autism spectrum disorders and severe behavior problems. The COMB treatment had shown a significant advantage for…
Descriptors: Behavior Disorders, Familiarity, Parents, Hyperactivity
Peer reviewedAman, Michael G. – Australia and New Zealand Journal of Developmental Disabilities, 1991
This paper identifies and evaluates emerging developments in the behavioral pharmacotherapy of people with developmental disabilities, including such medications as the opiate antagonists, fenfluramine, beta adrenergic blockers, buspirone, antipsychotics, amantadine hydrochloride, and antilibidinal drugs. The need for more well-designed drug…
Descriptors: Behavior Change, Behavior Problems, Developmental Disabilities, Drug Therapy
Jensen, Peter S.; Youngstrom, Eric A.; Steiner, Hans; Findling, Robert L.; Meyer, Roger E.; Malone, Richard P.; Carlson, Gabrielle A.; Coccaro, Emil F.; Aman, Michael G.; Blair, James; Dougherty, Donald; Ferris, Craig; Flynn, Laurie; Green, Evelyn; Hoagwood, Kimberly; Hutchinson, Janice; Laughren, Tom; Leve, Leslie D.; Novins, Douglas K.; Vitiello, Benedetto – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
Objective: To determine whether impulsive aggression (IA) is a meaningful clinical construct and to ascertain whether it is sufficiently similar across diagnostic categories, such that parallel studies across disorders might constitute appropriate evidence for pursuing indications. If so, how should IA be assessed, pharmacological studies…
Descriptors: Psychiatry, Public Health, Ethics, Clinical Experience
Peer reviewedAman, Michael G. – Australia and New Zealand Journal of Developmental Disabilities, 1985
Treatment of mentally retarded persons with psychotropic and anticonvulsant drugs is discussed in terms of drug classification, rationale for use, attitudes toward use, and clinical research findings. The literature on neuroleptic, anticonvulsant, anxiolytic, and cerebral stimulant drugs is summarized. Controversial reports that some medications…
Descriptors: Allied Health Personnel, Attitudes, Behavior Change, Biochemistry
Download full textNeef, Nancy A.; Bicard, David F.; Endo, Sayaka; Coury, Daniel L.; Aman, Michael G. – Journal of Applied Behavior Analysis, 2005
We used an assessment that involved competing reinforcer dimensions in a concurrent-schedules arrangement to examine the effects of stimulant medication on impulsivity (i.e., sensitivity of choices to reinforcer immediacy relative to rate, quality, and effort) with 4 students with attention deficit hyperactivity disorder. The assessments were…
Descriptors: Reinforcement, Pharmacology, Stimulants, Hyperactivity
Atomoxetine for Hyperactivity in Autism Spectrum Disorders: Placebo-Controlled Crossover Pilot Trial
Arnold, L. Eugene; Aman, Michael G.; Cook, Amelia M.; Witwer, Andrea N.; Hall, Kristy L.; Thompson, Susan; Ramadan, Yaser – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To explore placebo-controlled efficacy and safety of atomoxetine (ATX) for attention-deficit/hyperactivity disorder (ADHD) symptoms in children with autism spectrum disorders (ASD). Method: Children ages 5 to 15 with ASD and prominent ADHD symptoms were randomly assigned to order in a crossover of clinically titrated ATX and placebo, 6…
Descriptors: Hyperactivity, Autism, Drug Therapy, Attention Deficit Disorders
